Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19260,2840,1.18 [1.08-1.29],0.0004171411076085
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17384,979,1.27 [1.10-1.47],0.001285676875133
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13972,1851,1.13 [1.01-1.26],0.0291934732408796
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19217,727,1.21 [1.02-1.44],0.03029364187472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19945,66,1.66 [1.12-2.44],0.0108453419506933
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",15563,96,1.55 [1.06-2.25],0.0229204311409892
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19538,57,1.66 [1.09-2.52],0.0181262440079602
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19524,2266,1.12 [1.01-1.24],0.0388642881296952
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18950,60,1.77 [1.19-2.63],0.0050929220124831
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19713,938,1.17 [1.00-1.37],0.0435940572099078
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17121,905,1.19 [1.03-1.39],0.0216024556557033
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14556,59,1.81 [1.22-2.67],0.0030878015609395
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,14956,459,1.27 [1.02-1.58],0.0300429884560407
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19805,589,1.24 [1.03-1.49],0.0226481298449673
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,14738,241,1.57 [1.20-2.05],0.0008957154189584
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19746,66,1.61 [1.06-2.44],0.0240644523575032
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,14974,477,1.26 [1.01-1.56],0.0426355346287666
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18805,4308,1.08 [1.00-1.17],0.0467274720771396
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15823,1326,1.24 [1.08-1.42],0.0020195308452661
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19320,1836,1.17 [1.04-1.31],0.006991384054211
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15128,631,1.26 [1.03-1.52],0.0211060989330541
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18952,233,1.37 [1.04-1.80],0.0259682026316662
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Aortic aneurysm,19048,329,1.29 [1.02-1.65],0.0367535833746201
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiac arrest,10020,209,1.44 [1.08-1.92],0.0120443535635866
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Conduction disorders,16722,1112,1.16 [1.00-1.35],0.0445214701175137
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19695,1092,1.20 [1.03-1.39],0.0169077310188469
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12388,165,1.54 [1.16-2.04],0.0026807891374539
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12324,101,1.85 [1.43-2.40],3.073754892125961e-06
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypotension,19840,995,1.19 [1.02-1.38],0.0282066620938695
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15947,337,1.45 [1.16-1.81],0.00097474167613
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18829,110,1.48 [1.02-2.16],0.0415647230155296
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16634,1024,1.17 [1.00-1.37],0.0437029397136706
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19415,308,1.52 [1.23-1.88],8.874598534099962e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Right bundle-branch block,16000,390,1.31 [1.04-1.65],0.0227751629702803
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19414,307,1.52 [1.23-1.88],0.0001058530909806
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Any mental disorder,19382,3000,1.12 [1.02-1.23],0.0153530666258472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17352,970,1.18 [1.02-1.37],0.0302745440104838
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18832,79,1.56 [1.07-2.26],0.0199764165501675
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Neurological diseases,18858,2943,1.12 [1.02-1.22],0.0150617754952946
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19955,55,1.61 [1.03-2.52],0.0354385638211357
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19871,779,1.23 [1.05-1.45],0.0106415063692149
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19671,579,1.32 [1.10-1.57],0.0022168184226489
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19231,2137,1.12 [1.00-1.24],0.0463431822679761
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19771,1093,1.18 [1.01-1.37],0.0329216247493768
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19164,298,1.30 [1.01-1.66],0.0404039015805903
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19748,1732,1.17 [1.04-1.31],0.0083374062280953
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,19185,319,1.30 [1.02-1.65],0.0318863991833912
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,19720,1830,1.20 [1.08-1.34],0.0012148210678748
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19863,388,1.27 [1.02-1.60],0.0339076775565761
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural effusion,18812,922,1.26 [1.09-1.47],0.0021019618875944
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19541,1525,1.20 [1.06-1.35],0.0031323911352311
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,13974,74,1.85 [1.38-2.50],4.943576175876581e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Coeliac disease,18579,77,1.79 [1.32-2.42],0.0001687342623778
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19915,335,1.30 [1.03-1.64],0.028639150498081
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19215,52,1.63 [1.08-2.46],0.0196719580514722
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18592,90,1.72 [1.28-2.30],0.000296837097914
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophagitis,15562,517,1.25 [1.02-1.52],0.0273916838023334
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19194,143,1.44 [1.06-1.96],0.0194637470517253
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19861,281,1.34 [1.05-1.71],0.018463291805873
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Toxic colitis,18748,38,1.80 [1.11-2.92],0.0164842809900222
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15293,248,1.32 [1.01-1.73],0.0398281537114616
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19092,76,1.53 [1.00-2.34],0.0482344364848054
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18676,1251,1.17 [1.02-1.34],0.020297841779875
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16118,1896,1.14 [1.02-1.28],0.0177824764558368
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17609,184,1.38 [1.03-1.85],0.0330943660559258
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15859,27,2.04 [1.23-3.41],0.0060298089121836
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17248,106,0.46 [0.22-0.98],0.0446731003826365
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19218,1490,1.30 [1.15-1.46],1.5463395391841942e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19356,123,1.48 [1.06-2.07],0.0220590511454359
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18846,1118,1.30 [1.13-1.49],0.0002072055163366
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Dialysis,17795,67,1.84 [1.28-2.62],0.0008631394432573
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19899,439,1.33 [1.08-1.64],0.0072581852756318
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18677,1233,1.21 [1.06-1.38],0.005817309633574
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19601,141,1.42 [1.02-1.99],0.0406802415341135
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19743,2238,1.21 [1.09-1.34],0.0002315325050053
